Literature DB >> 19019440

C-mip interacts physically with RelA and inhibits nuclear factor kappa B activity.

Maud Kamal1, Asta Valanciute, Karine Dahan, Virginie Ory, Andre Pawlak, P Lang, Georges Guellaen, Djillali Sahali.   

Abstract

The fine regulation of NF-kappaB activity is crucial for both resting and stimulated cells and relies on complex balance between multiple activators and inhibitors. We report here that c-mip, a recently identified pleckstrin homology (PH) and leucine-rich repeat (LRR)-domain-containing protein, inactivates GSKbeta and interacts with RelA, a key member of the NF-kappaB family. We show that c-mip inhibits the degradation of I-kappaBalpha and impedes the dissociation of the NF-kappaB/I-kappaBalpha complexes. C-mip acts downstream signaling of classical NF-kappaB pathway and may represent one of the missing links in the control of NF-kappaB activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019440     DOI: 10.1016/j.molimm.2008.09.034

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  14 in total

Review 1.  Immunopathogenesis of idiopathic nephrotic syndrome with relapse.

Authors:  Djillali Sahali; Kelhia Sendeyo; Melanie Mangier; Vincent Audard; Shao Yu Zhang; Philippe Lang; Mario Ollero; Andre Pawlak
Journal:  Semin Immunopathol       Date:  2014-01-09       Impact factor: 9.623

2.  Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes.

Authors:  Vincent Audard; Shao-yu Zhang; Christiane Copie-Bergman; Catherine Rucker-Martin; Virginie Ory; Marina Candelier; Maryse Baia; Philippe Lang; André Pawlak; Djillali Sahali
Journal:  Blood       Date:  2010-03-03       Impact factor: 22.113

3.  Recent advances in the genetics of language impairment.

Authors:  Dianne F Newbury; Simon E Fisher; Anthony P Monaco
Journal:  Genome Med       Date:  2010-01-26       Impact factor: 11.117

Review 4.  Genetic advances in the study of speech and language disorders.

Authors:  D F Newbury; A P Monaco
Journal:  Neuron       Date:  2010-10-21       Impact factor: 17.173

5.  Exome sequencing in an admixed isolated population indicates NFXL1 variants confer a risk for specific language impairment.

Authors:  Pía Villanueva; Ron Nudel; Alexander Hoischen; María Angélica Fernández; Nuala H Simpson; Christian Gilissen; Rose H Reader; Lillian Jara; María Magdalena Echeverry; Maria Magdalena Echeverry; Clyde Francks; Gillian Baird; Gina Conti-Ramsden; Anne O'Hare; Patrick F Bolton; Elizabeth R Hennessy; Hernán Palomino; Luis Carvajal-Carmona; Joris A Veltman; Jean-Baptiste Cazier; Zulema De Barbieri; Simon E Fisher; Dianne F Newbury
Journal:  PLoS Genet       Date:  2015-03-17       Impact factor: 5.917

6.  Effects of Genetic Loci Associated with Central Obesity on Adipocyte Lipolysis.

Authors:  Rona J Strawbridge; Helmut Laumen; Anders Hamsten; Michaela Breier; Harald Grallert; Hans Hauner; Peter Arner; Ingrid Dahlman
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

7.  Opposite Genetic Effects of CMIP Polymorphisms on the Risk of Type 2 Diabetes and Obesity: A Family-Based Study in China.

Authors:  Yaying Cao; Tao Wang; Yiqun Wu; Juan Juan; Xueying Qin; Xun Tang; Tao Wu; Yonghua Hu
Journal:  Int J Mol Sci       Date:  2018-03-28       Impact factor: 5.923

Review 8.  Neurogenomics of speech and language disorders: the road ahead.

Authors:  Pelagia Deriziotis; Simon E Fisher
Journal:  Genome Biol       Date:  2013-04-18       Impact factor: 13.583

9.  CMIP and ATP2C2 modulate phonological short-term memory in language impairment.

Authors:  Dianne F Newbury; Laura Winchester; Laura Addis; Silvia Paracchini; Lyn-Louise Buckingham; Ann Clark; Wendy Cohen; Hilary Cowie; Katharina Dworzynski; Andrea Everitt; Ian M Goodyer; Elizabeth Hennessy; A David Kindley; Laura L Miller; Jamal Nasir; Anne O'Hare; Duncan Shaw; Zoe Simkin; Emily Simonoff; Vicky Slonims; Jocelynne Watson; Jiannis Ragoussis; Simon E Fisher; Jonathon R Seckl; Peter J Helms; Patrick F Bolton; Andrew Pickles; Gina Conti-Ramsden; Gillian Baird; Dorothy V M Bishop; Anthony P Monaco
Journal:  Am J Hum Genet       Date:  2009-07-30       Impact factor: 11.025

10.  CMIP interacts with WT1 and targets it on the proteasome degradation pathway.

Authors:  Shao-Yu Zhang; Qingfeng Fan; Anissa Moktefi; Virginie Ory; Vincent Audard; Andre Pawlak; Mario Ollero; Dil Sahali; Carole Henique
Journal:  Clin Transl Med       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.